Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the UAE.

  1. Article
  2. Source: Campus Sanofi
  3. 30 Apr 2025

Dupixent® (dupilumab) Mechanism of Action

Author: Sanofi

Editorial Team

   

Dupixent binds to IL-4Rα, blocking IL-4 and IL-13 intracellular signaling, Two Type 2 Cytokines that contribute to Inflammation in Asthma.

MAT-KW-2400500-V1-Jan 2025  

Related

Back to top
Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
SitemapLegal noticePrivacy PolicyCookie PolicyContactAccessibility statement

© Sanofi 2004-2026 - All rights reserved

MAT-AE-2100444/V8/JUL2025

Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
SitemapLegal noticePrivacy PolicyCookie PolicyContactAccessibility statement
Back to top

© Sanofi 2004-2026 - All rights reserved

MAT-AE-2100444/V8/JUL2025